Ebpay生命医药出版社

Ebpay生命

102445

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

成人阻塞性睡眠呼吸暂停患者血清神经递质与认知功能障碍的关系

 

Authors Yang F, Zhu S , Lv X, Zhou Y, Wang Z, Lu C, Xia Z, Liu H, Hou J, Yan J , Chen J, Lv H, Shi Y, Ren X

Received 22 February 2025

Accepted for publication 9 May 2025

Published 30 May 2025 Volume 2025:17 Pages 1127—1141

DOI http://doi.org/10.2147/NSS.S522352

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Ahmed BaHammam

Fangli Yang,* Simin Zhu,* Xinru Lv, Yanuo Zhou, Zitong Wang, Chendi Lu, Zihan Xia, Haiqin Liu, Jin Hou, Jing Yan, Jingguo Chen, Hui Lv, Yewen Shi, Xiaoyong Ren

Department of Otorhinolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Yewen Shi, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 Xi Wu Road, Xi’an, Shaanxi Province, People’s Republic of China, Tel +86-13572247767, Email shiyewen59@outlook.com Xiaoyong Ren, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 Xi Wu Road, Xi’an, Shaanxi Province, People’s Republic of China, +86-13509183366, Email cor_renxiaoyong@126.com

Introduction: The primary aim of this study was to investigate the serum levels of acetylcholine (Ach), norepinephrine (NE), dopamine (DA), and 5-hydroxytryptamine (5-HT) in two groups: those with obstructive sleep apnea (OSA) and cognitive impairment (CI) and those with OSA but no cognitive impairment (NCI).
Methods: A total of 30 adults (CI) and 75 adults (NCI) who completed polysomnography examinations between December 2023 and September 2024 were enrolled in the study. Enzyme-linked immunosorbent assays were used to measure serum levels of Ach, NE, DA, and 5-HT. Correlation and pooled analyses were conducted to assess the relationship between cognitive scores and four serological indicators. Logistic regression was performed to identify risk factors for cognitive impairment.
Results: Serum DA levels were higher in the CI group (275.10, 216.73– 426.91, pg/mL) than in the NCI group (219.69, 138.46– 261.97, pg/mL) (P < 0.001). No significant differences were found in serum NE, 5-HT, and Ach levels between the two groups (P = 0.582, P = 0.287, and P = 0.715, respectively). Moreover, the correlation analysis showed a correlation between DA and body mass index, Montreal Cognitive Assessment, average saturated oxygen (SaO2), minimum SaO2, the percentage of oxygen saturation less than 90% (all P < 0.05). The area under the receiver operating characteristic curve of DA was 0.732 (95% confidence interval: 0.628– 0.836) (P < 0.001). Logistic regression analysis revealed a correlation between tonsil size, hypertension, DA, stuffy nose, and cognitive impairment.
Conclusion: Serum DA levels were associated with the severity of cognitive impairment in adults diagnosed with OSA and might serve as a potential, objective biomarker for identifying cognitive dysfunction in this population.

Keywords: neurotransmitter, acetylcholine, norepinephrine, dopamine, 5-hydroxytryptamine, cognitive dysfunction, obstructive sleep apnea

Download Article[PDF]